R&D
Pipeline
Combination Therapies
| 파이프라인 | 후보물질 | 전임상 | 임상1상 | 임상2상 | 임상3상 | 비고 | MB-110(PDI inhibitors) | Protein-DNA interaction inhibotor | MB-610(Drug repositioning) | Known Factor M inhibitor | MB-620(Drug repositioning) | FDA 승인 drug library에서 Factor M inhibitor 예비 선도 물질 발굴 |
|---|
Companion Diagnostics
| Biomarker Selection |
Feasibility | Prototype Assay |
Analytical Validation |
Clinical & Analytical Validation |
Regulatory Approval |
Post Approval | MB-CDx |
|---|
+82-2-710-9560
+82-2-2077-7322